An interleukin-2 (IL-2) variant containing adjacent point mutations (L18M/L19S, termed 2D1) displaying binding affinity to the heterotrimeric IL-2 receptor similar to that of wild-type IL-2 (WT) had been previously found to surprisingly exhibit increased bioactivity in a peripheral blood lymphocyte proliferation assay. In order to provide an explanatory mechanism for this unexpected potency enhancement, we hypothesize that altered endocytic trafficking of the 2D1 variant might be responsible by increasing the number of ligand-receptor complexes. We demonstrate here that the internalization kinetics of 2D1 via the high affinity IL-2 receptor are equivalent to those of WT but that a significantly increased fraction of internalized 2D1 is sorted to recycling instead of to lysosomal degradation. We further find a reduced pH sensitivity of binding to IL-2 receptor ␣ relative to IL-2 receptor ␤ compared with WT, which could be responsible for the altered sorting behavior of 2D1 in the acidic endosomal compartment. Accordingly, the 2D1 variant displays a half-life 36 h longer than that of IL-2 in T-lymphocyte culture at concentrations equal to the K D of the IL-2 receptor. The extended half-life of intact 2D1 provides enhanced mitogenesis as compared with IL-2. In addition, 2D1 stimulates natural killer cells to a lesser degree than IL-2 at equal concentrations. We conclude that this IL-2 variant provides increased mitogenic stimulation that could not be easily predicted from its cell surface receptor binding affinity while minimizing undesired stimulation of natural killer cells. This concept of altering trafficking dynamics may offer a generalizable approach to generating improvements in the pharmacological efficacy of therapeutic cytokines.
The diverse cell-mediated events of immune and inflammatory responses are tightly regulated by cytokines, and these proteins have been extensively studied as targets for therapeutic intervention (1) . Cytokines direct communication among cells of the hematopoietic system by binding to specific cell surface receptors (2) . These receptors generally bind their soluble ligands with very high affinity; thus, optimum response requires delivery of cytokines to target cells at very low concentrations (ϳ10 Ϫ10 -10 Ϫ12 M). These low levels are difficult to sustain due to rapid systemic clearance. Endocytosis of cytokines via their cognate receptors provides cells with an efficient means of modulating their response to ligand-receptor binding events (3) . This down-regulatory mechanism can cause significant depletion of therapeutic cytokines, however, creating the need to deliver unphysiologically high doses in order to maintain reasonable in vivo concentrations (4, 5) . High bolus concentrations often produce toxic, sometimes lethal, side effects (6, 7) .
Interleukin-2 (IL-2) 1 was initially isolated as a T cell growth factor and has since been shown to direct the expansion and differentiation of several hematopoietic cell types (8, 9) . Clinical studies using IL-2 in the treatment of AIDS have been encouraging, due to its critical role as a proliferative signal for activated T-lymphocytes (10 -14) . IL-2 has also undergone trials in the treatment of several types of cancer, based on its stimulation of cytotoxic, antitumor cells (15) (16) (17) (18) . Toxicity has severely limited the effectiveness of IL-2 treatments, however, making cell receptor-level pharmacodynamic issues crucial in expanding its therapeutic applicability (19, 20) . Pharmacokinetics can be addressed on both a systemic level and at the site of IL-2 activity, the IL-2 receptor (IL-2R) expressed in various forms on hematopoietic cells (21) . Cell-level pharmacokinetics involves consideration of receptor-mediated endocytic turnover and intracellular degradation of internalized cytokine molecules that, over time, leads to depletion of ligand from the extracellular medium (22) .
The IL-2 receptor on activated T-lymphocytes consists of ␣, ␤, and ␥ subunits, the latter two of which have been shown to mediate IL-2-induced proliferative signaling in these cells (23, 24) . Expression of the ␣ subunit is up-regulated by T cells upon antigen activation and is thus found in ϳ100-fold excess on the surface of activated T cell populations (8) . The ␣ subunit serves solely to enhance the affinity of the IL-2R complex for soluble IL-2 (25, 26) and is not involved in signaling as it possesses only 13 residues in its cytoplasmic domain (27) . This heterotrimeric receptor binds with high affinity to IL-2 (K D ϭ 10 pM), followed by rapid internalization and specific degradation of both IL-2 and the ␤ and ␥ subunits (28 -31) . Consistent with its role as a signaling-deficient enhancer of cell surface ligand binding affinity, the ␣ subunit is constitutively recycled following postendocytic sorting (31) . Therefore, receptor-ligand trafficking dynamics should influence the potency of IL-2 to at least as significant a degree as receptor binding affinity, as has been illustrated in the epidermal growth factor ligand-receptor system (32, 33) .
The functional ␤ and ␥ IL-2 receptor subunits are also constitutively expressed on natural killer (NK) cells, thus allowing this cell type to respond to IL-2 through up-regulation of cytokine secretion and enhancement of cytotoxicity (34, 35) . IL-2 therapies have been hampered by a therapeutic "window" in concentration, defined at the upper end by undesired stimulation of intermediate affinity (K D Ϸ 0.1-10 nM) ␤␥ IL-2 receptors on NK cells, and at the lower end by desired stimulation of high affinity (K D Ϸ 1-100 pM) ␣␤␥ IL-2 receptors on antigen-activated T and B cells (14, 20) . Dangerous inflammatory responses are activated at the upper end of IL-2 concentration, whereas therapeutic effects are not observed below the lower end.
We demonstrate that a double mutant of IL-2, L18M/L19S (termed 2D1) displays reduced endocytic degradation when compared with wild-type IL-2 (WT) and that this effect is due to enhanced ligand recycling. Analysis of ligand binding to the IL-2R ␣ and ␤ subunits at cell surface and endosomal pH indicates that the affinity of 2D1 for IL-2R␣ decreases to a lesser degree than that of WT as ligand-receptor complexes undergo sorting. These intracellular trafficking differences permit greater sustenance of 2D1 concentrations in cell culture, and increased T-lymphocyte proliferation. The reduced binding affinity of 2D1 to the ␤␥ IL-2R on NK cells also provides reduced stimulation of these cells, a desired outcome in an in vivo setting. This suggests that IL-2 mutants engineered for improved cellular pharmacokinetics and optimal binding affinities to cell type-specific IL-2 receptor isoforms can provide enhanced mitogenic response of T-lymphocytes while minimizing potential in vivo toxicity.
EXPERIMENTAL PROCEDURES
Materials-RPMI 1640 medium, L-glutamine, and Dulbecco's phosphate-buffered saline (PBS) were obtained from Life Technologies, Inc. Fetal bovine serum was obtained from Intergen (Purchase, NY). Solution for the Coulter counter (ISOTON II, Coulter Diagnostics, Hialeah, FL) was acquired from Curtin Matheson Scientific Inc. (Houston, TX). 125 I was obtained from NEN Life Science Products. Wild-type IL-2 and 2D1 (L18M/L19S) were previously prepared via cassette mutagenesis on a synthetic IL-2 gene (36, 37) . Proteins were expressed in E. coli, refolded, and purified as described previously (38) . Concentrations of purified proteins were determined by UV absorption (⑀ 280 ϭ 9.53 ϫ 10 3 M Ϫ1 ) (39) . Radioiodinated IL-2 and 2D1 were prepared using the indirect IODO-GEN method according to the manufacturer's protocol (Pierce). Specific activities were determined by CTLL bioassay (40) and ranged from 2 to 4 Ci/mol.
Cell Culture-The KIT-225 human IL-2-dependent cell line, originally derived from a T-lymphocytic leukemia patient, expresses roughly 3000 high affinity IL-2 receptors (IL-2R␣␤␥, K D ϭ 10 pM) and 300,000 low affinity sites (IL-2R␣, K D ϭ 10 nM) (41, 42) . The YT-2C2 human leukemic NK cell line expresses approximately 20,000 intermediate affinity IL-2 receptors (IL-2R␤␥, K D ϭ 1 nM) (43) . KIT-225 cells were routinely cultured in Corning 75-cm 2 tissue culture flasks in RPMI 1640 medium supplemented with 1 nM IL-2, 200 mM L-glutamine, 50 g/ml gentamycin, 50 units/ml penicillin, and 10% heat-inactivated fetal bovine serum in a humidified atmosphere with 5% CO 2 . YT-2C2 cells were cultured in the same medium without IL-2. All cells were passaged to 10 5 cells/ml every 2-3 days.
Internalization of
125 I-Labeled IL-2 and 2D1-Internalization experiments were performed in a 96-well format using the MultiScreen Assay System (Millipore, Bedford, MA). The bottom of each well in a MultiScreen microtiter plate consists of a low protein binding, semipermeable (0.65 m pore size) membrane that provides separation of cellassociated ligand and free protein upon vacuum filtration of the plate base. KIT-225 cells were washed three times with supplemented RPMI 1640 medium to remove exogenous IL-2 and were resuspended at 4 ϫ 10 6 cells/ml. 100 l of the cell suspension was loaded into each well, and cells were exposed to a range of labeled ligand concentrations (1-200 pM) for 0 -30 min at 37°C to allow receptor-mediated endocytosis to occur. Following ligand exposure, free protein was suctioned through the base of the plate, and wells were washed six times with 250 l of ice-cold PBS. Half of the plate was then exposed to three 250-l rinses of acid strip containing urea (10 mM citrate, 0.14 M NaCl, 50 g/ml BSA, and 2 M urea, pH 2.8) for 3 min each to remove cell surface-bound ligand. Strip efficiency was determined to be ϳ90% in control experiments. The remaining half of the plate was simultaneously rinsed with PBS, and membranes were then counted individually by solid scintillation. Stripped wells were considered as internalized counts (C i ) and PBS-rinsed wells as total counts (C T ), the difference being cell surfaceassociated (C s ). Each data point was measured in triplicate, subtracting membrane-bound ligand in the absence of cells. An endocytic rate constant (k e ) was calculated for each ligand concentration as the slope of a straight-line fit to a plot of C i versus ͐ C s ⌬t, as described (44) .
Steady I-2D1 (10 -100 pM) at 5 ϫ 10 6 cells/ml. Cells were incubated for 3 h at 37°C to allow intracellular sorting processes to reach steady state, as described previously (45, 46) . Samples were cooled to 4°C and washed twice with ice-cold PBS, followed by two washes with ice-cold acid strip (10 mM citrate, 0.14 M NaCl, 50 g/ml BSA, pH 2.8) to remove surface bound 125 I-ligand. This strip protocol removed all the cell surfaceassociated label, as indicated by control experiments in which cells were incubated with radiolabeled ligands for 3 h at 4°C prior to washing. After an additional wash with ice-cold PBS, cells were resuspended at 37°C in medium containing 200 nM unlabeled IL-2 to prevent rebinding of released, labeled ligands to cell surface receptors. Aliquots containing 5 ϫ 10 6 cells were removed to Eppendorf tubes at 0, 5, 10, and 15 min and pelleted. The supernatant was collected, and the cell pellet was rinsed in ice-cold medium and pelleted again. Cell pellets were resuspended in 1 M NaOH and counted by solid scintillation to calculate intracellular ligand concentrations. Supernatants were combined and counted to determine the amount of radioactivity released by the cells. Parallel samples were centrifuged through 10-kDa-molecular mass cutoff filtration units to separate intact from degraded 125 I-ligand (Ultrafree-MC, Millipore). Parallel samples passed through Sephadex G-10 columns provided equally reliable results.
Surface Plasmon Resonance Analysis of Ligand Binding to IL-2R
Complexes-Surface plasmon resonance analysis of WT and 2D1 binding to immobilized IL-2R␣ and IL-2R␤ ectodomains was performed as described (47) . Sensor chip surfaces with oriented IL-2R␣ or IL-2R␤ subunits were prepared via thioether linkages at single cysteine residues present in the native extracellular domain (IL-2R␣) or introduced by mutagenesis (IL-2R␤) (48) as described previously (49) . Surface plasmon resonance instrumentation (BIAcore TM ), CM5 sensor chips, and amine-coupling reagents containing N-hydroxysuccinimide, N-ethyl-NЈ-(3-diethyl-aminopropyl)carbodiimide, and ethanolamine HCl were obtained from Amersham Pharmacia Biotech. Thiol conjugation was achieved using m-maleimidobenzoyl-N-hydroxysuccinimide ester (Pierce). Purified IL-2R␣ or IL-2R␤ complex was diluted into NaOAc buffer (10 mM), pH 5, and coupled to the dextran-modified gold surface of a CM5 sensor chip using the manufacturer's coupling chemistry as described in the BIAcore TM systems manual. Surface densities of 800 -3500 resonance units of IL-2R complex were used. Prior to analysis, stock solutions of WT and 2D1 were dialyzed against phosphate buffer (10 mM sodium phosphate, pH 7.2 or pH 6, 150 mM NaCl), and protein concentrations were determined from A 280 values (37) . Samples were then diluted to desired concentrations in analysis buffer (10 mM sodium phosphate, pH 7.2 or pH 6, 150 mM NaCl, 0.005% surfactant P-20) containing 100 g/ml bovine serum albumin. Six to eight serial dilutions of each protein were injected over the respective surfaces at a flow rate of 10 l/min. Sensorgrams were recorded and normalized to a baseline value of 0 RU. Equivalent samples were injected over BSA surfaces for simultaneous subtraction of nonspecific binding and bulk refractive index background. Each determination was performed in triplicate, and the same surface was used for each set of data collected at pH 7.2 and pH 6.
Because binding of WT and 2D1 reached a constant equilibrium value during injection on both IL-2R complex surfaces at pH 7.2 and pH 6, this equilibrium value (RU eq ) was used to fit the data to a single-site binding isotherm (A ϩ B ϭ AB) at each condition. After subtraction of background and nonspecific RU (determined by injection over a BSA surface), RU eq was plotted versus C, the concentration of ligand injected over the sensor chip surface. The dissociation constants were estimated by weighted, nonlinear least squares curve fitting using KaleidaGraph TM (version 3.09, Synergy Software).
Growth Experiments and Cell Surface Receptor Quantification-KIT-
225 cells were passaged into supplemented RPMI 1640 medium (without IL-2) at 2 ϫ 10 5 cells/ml 6 days prior to the addition of exogenous IL-2 analogs. Cells were switched into fresh IL-2-free medium on day 3 of quiescence. Growth experiments were initiated by switching cells into media containing a range of ligand concentrations (1, 10, and 100 pM). Cells were counted in a Coulter counter to monitor growth. Cell aliquots from equivalent populations were washed in ice-cold medium and resuspended in medium containing 500 pM 125 I-IL-2 at approximately 2 ϫ 10 6 cells/ml. Cell suspensions were transferred to 0.65 m MultiScreen microtiter plates and incubated for 3 h at 4°C. Following incubation, free protein was suctioned through the base of the plate, and wells were washed six times with 250 l of ice-cold PBS. Membranes were then counted individually by solid scintillation to determine cell surface-associated radioactivity. Each data point was measured in triplicate, subtracting nonspecific binding as determined by addition of 200-fold molar excess of unlabeled wild-type IL-2.
Intact Ligand Quantification-Quiescent KIT-225 cells or YT-2C2 cells were incubated in media containing 125 I-labeled ligands. Controls for nonspecific degradation included incubation with 200-fold molar excess of unlabeled IL-2. Cell aliquots were removed and pelleted every 12 h, and supernatants were centrifuged through 10-kDa-molecular mass cutoff filtration units to separate intact from degraded 125 I-ligand. This method proved to be equivalent to gel filtration in quantifying relative amounts of degraded protein.
Determination of IL-2-Induced IFN-␥ Secretion-YT-2C2
cells were incubated for 48 h in medium containing 1 nM IL-2 or 2D1. At that time, the concentration of IFN-␥ was determined using an enzyme-linked immunosorbent assay kit obtained from Intergen (Purchase, NY). No cross-reactivity of the IFN-␥ antibody was observed with either WT or 2D1 under experimental conditions (data not shown). Medium samples were centrifuged to remove cellular debris prior to analysis.
RESULTS

Selection of IL-2 Variant L18M/L19S (2D1)-
A double mutant of IL-2, L18M/L19S (2D1), was shown to yield an equivalent biological response to wild-type at a 2-fold lower concentration (Table I) (37) . One possible explanation for this enhanced potency might be increased binding to the high affinity IL-2 receptor (␣␤␥ complex) expressed on activated Tlymphocytes. This would be expected to generate more ligandreceptor complexes at a given cytokine concentration, resulting in up-regulated cell proliferation (50) . The binding affinities of WT and 2D1 to the ␣␤␥ complex are roughly equivalent, however, requiring an alternative explanation for the superagonism of 2D1 (Table II) (37) . We sought to characterize the trafficking behavior of WT and 2D1 as a potential source of their differences in observed mitogenic potency.
Receptor-mediated Endocytosis of WT and 2D1-A different IL-2 variant, T51P, had been previously shown to be deficient in receptor-mediated endocytic uptake, resulting in negligible cellular depletion of ligand from the culture medium. Therefore, despite a reduced receptor binding affinity, T51P generated a proliferative response equivalent to that of WT due to abrogated down-regulation of ligand-receptor complexes from the cell surface (51) . To test whether this mechanism was responsible for the enhanced mitogenic potency of 2D1, we measured the internalization rates of WT and 2D1 on T-lymphocytes. The KIT-225 human cell line was chosen because it is IL-2-dependent, providing the opportunity to correlate receptor-mediated trafficking events and mitogenesis within a single system. Cells were incubated with ligand concentrations both below and above the K D of the high affinity IL-2 receptor (10 pM) to investigate endocytic behavior at potentially subsaturating and saturating conditions (52) . Radiolabeled WT and 2D1 were internalized with comparable rates at both low and high surface receptor occupancy (Fig. 1) . Over most of the occupancy range, the internalization rate constants fell within the interval of 0.03-0.04 min Ϫ1 , which corresponds to the internalization half-time of 17-23 min observed in activated peripheral blood lymphocytes (51) . Surface binding and receptor-mediated endocytosis of 2D1 are thus indistinguishable from WT. The increase in the value of the internalization rate constant with increasing receptor occupancy at low concentrations is intriguing and may indicate an interesting regulation point; this phenomenon, however, is beyond the scope of the present work.
Steady-state Sorting of WT and 2D1-We therefore hypothesized that altered intracellular sorting might be the trafficking process responsible for the differential bioactivity. To measure trafficking events downstream of internalization, cells were allowed to process radiolabeled WT or 2D1 until the sorting process reached steady state (46) . Exogenous and surfacebound proteins were removed at 4°C (to inhibit endocytosis), and the initial rate of ligand release was measured by collecting media up to 15 min after returning the cells to 37°C. Sorting fractions were measured by filtering samples through 10-kDa-molecular mass cutoff membranes and counting the radioactivity in the filtrate and retentate. Over the range of extracellular ligand concentrations tested (10 -100 pM), the 2D1 variant was recycled to a significantly greater extent than WT (Fig. 2) . The fraction of 2D1 recycled was nearly 50%, whereas only 20 -35% of intracellular WT was released intact. These sorting results further confirm the equivalence of binding and internalization events for WT and 2D1, because the numbers of intracellular complexes were roughly equivalent.
Surface Plasmon Resonance Analysis of Ligand Binding to IL-2R␣ and ␤ Subunits-The pH sensitivity of ligand-receptor interactions has been shown to be a crucial factor in affecting endosomal sorting outcomes (45) . In the IL-2R system, the ␤ and ␥ subunits are preferentially degraded, whereas the ␣ subunit recycles following IL-2 binding and internalization (31) . Thus, it follows that the relative affinity of an IL-2 analog for these individual receptor subunits as pH is decreased from ϳ7.2 at the cell surface to ϳ6 in endosomes should directly affect the sorting fate of the ligand. We chose to examine the affinity of WT and 2D1 to the ␣ and ␤ subunits, individually, at both pH 7.2 and pH 6 using surface plasmon resonance (BIAcore TM ) analysis. Because the ␥ subunit displays equivalent sorting behavior to IL-2R␤, exhibits extremely low binding affinity to IL-2 (K D Ͼ 50 M) (53), and is unstable to the low pH conditions required to prepare and regenerate biosensor surfaces, binding to IL-2R␥ was not examined. Experiments were performed at pH 7.2 and pH 6, and equilibrium RU values were plotted versus the concentration of ligand for IL-2R␣ and IL-2R␤ surfaces, as shown in Fig. 3, A and B, respectively. The (37) .
binding of IL-2 to these biosensor surfaces has been previously characterized, and the kinetic and equilibrium binding constants were similar to those obtained in cell-based assays (47, 49) . The data were fit to a single-site binding model under each experimental condition, and the resulting dissociation constants are listed in Table III . An equivalent 10-fold decrease in affinity to IL-2R␤ was observed for both WT and 2D1 as pH was reduced from 7.2 to 6. The affinity of WT for IL-2R␣ was reduced 8-fold, whereas that of 2D1 was reduced only 5-fold as pH decreases from 7.2 to 6. The potential effect of these affinity changes on ligand sorting behavior can be visualized by plotting the ratio of dissociation constants for the ␣ versus ␤ subunits at pH 6 relative to pH 7.
2) for both WT and 2D1 IL-2 (Fig. 4) . This ratio represents the change in relative preference for ligand binding to IL-2R␣ versus IL-2R␤ as the complex moves from the cell surface to the endosomal sorting compartment. The greater the value of this ratio, the greater the proclivity the ligand should have for endosomal sorting toward recycling along with IL-2R␣ rather than toward lysosomal degradation along with IL-2R␤. Fig. 4 shows that this ratio is clearly greater for 2D1 than for WT, consistent with our findings shown in Fig. 2 .
Ligand Depletion by T Cells in Culture-Proliferating T cells are known to deplete IL-2 as a means of down-regulating their mitogenic stimulus (54) . We sought to determine whether the altered intracellular sorting of 2D1 provided this variant with improved pharmacokinetics in culture. KIT-225 cells were starved of IL-2 as described under "Experimental Procedures" and incubated with radiolabeled WT or 2D1 at concentrations of 10 or 100 pM. These concentrations were chosen to approximate 50 and 100% occupancy of high affinity IL-2 receptors, respectively. Intact ligand remaining in 5-day cultures was quantified every 12 h by passing samples of the cell supernatant through 10-kDa-molecular mass cutoff membranes. Medium containing 10 pM radiolabeled ligand was depleted more rapidly by the cells than medium containing 100 pM ligand for both WT and 2D1. This result is consistent with a depletion mechanism wherein a fixed number of molecules is processed by a constant number of cells in a given time. Thus, the larger pool of labeled ligands (100 pM) is depleted less rapidly than the smaller population (10 pM). The degradation of both proteins was abrogated by co-incubating cells with a 200-fold excess of unlabeled WT, indicating that ligand consumption was mediated specifically by the IL-2 receptor (Fig. 5) . Wild-type IL-2 was degraded at a significantly faster rate than 2D1 for both conditions, although the difference in depletion rate for 100 pM starting concentrations was not apparent until day 3 due to the larger pool of extracellular ligand molecules (Fig. 5) . The viable concentration of 10 pM WT in the medium was halved within 48 h, whereas the half-life of 10 pM 2D1 was 84 h. Therefore, at cytokine concentrations near the K D of the high affinity IL-2 receptor (10 pM), the 2D1 mutant should retain its efficacy longer than IL-2 due to its enhanced stability to receptormediated degradation.
Cell Surface Receptor-Ligand Complex Numbers-Cells receive their mitogenic stimulus from IL-2/IL-2R complexes on the cell surface. Thus, quantification of IL-2 receptor numbers was necessary to fully determine the effects of ligand depletion on cell proliferation. Quiescent KIT-225 cells were incubated with WT or 2D1 at concentrations of 10 pM or 100 pM. Cell aliquots were removed every 24 h, and radioreceptor binding assays were performed at 4°C using 500 pM 125 I-WT to saturate high affinity receptors. Receptor levels were depressed on day 1 following quiescence. Upon exposure to either WT or 2D1, receptor levels increased throughout the 5-day culture, presumably due to enhanced IL-2R␣ expression (Fig. 6 ). This effect was likely due to up-regulation of IL-2R␣ upon introduction of IL-2, which has been described as occurring both in activated peripheral blood lymphocytes and in another human leukemic T cell line (31, (55) (56) (57) (58) . Receptor numbers increased at equivalent rates for both ligands at 10 pM starting concentrations and then displayed relatively constant levels beginning at day 3. Cell surface receptor levels increased throughout the 5-day culture for both WT and 2D1 at 100 pM, with a significantly greater increase observed in the presence of 2D1 at later times.
Receptor data were combined with results of the ligand depletion studies to estimate cell surface ligand-receptor complex numbers at each time using the following relationship:
where R is the number of receptors per cell, L is the intact ligand concentration as shown in Fig. 5 , and K D is the respective equilibrium dissociation constant describing binding of WT or 2D1 to the high affinity IL-2R (see Table II ). Although the receptor levels seen in the presence of 10 pM WT and 10 pM 2D1 are essentially equal, the reduced depletion of 2D1 leads to greater predicted ligand-receptor complex numbers up to day 3, followed by a decrease upon eventual depletion of this ligand (Fig. 7) . Depletion is less significant at 100 pM ligand concentrations, so the predicted complex numbers track in accord with the receptor numbers shown in Fig. 6 . Table III were used to calculate the ratio of ligand affinity for IL-2R␣ versus IL-2R␤ for WT (black bar) relative to 2D1 (gray bar). The magnitude of this ratio represents the enhancement of ligand affinity to IL-2R␣ relative to IL-2R␤ as pH is decreased from 7.2 to 6. 6 cells/ml in ice-cold RPMI ϩ 10% fetal calf serum containing 500 pM 125 I-IL-2 to saturate high affinity receptors. Nonspecific binding was subtracted from each measurement by incubating cells with 200-fold molar excess of unlabeled wild-type IL-2. Cells were incubated for 3 h at 4°C, separated from free ligand using the Millipore MultiScreen unit, and then washed six times with ice-cold PBS. Parallel cell samples were counted to determine receptor number per cell, and results were normalized to values on day 1. Results shown are the mean Ϯ S.E. of two independent experiments. data were previously obtained on activated peripheral blood lymphocytes, and 2D1 was shown to induce a mitogenic response equivalent to WT at a 2-fold lower concentration in 48-h assays (Table I) . Proliferation of KIT-225 cells was monitored to determine the influence of ligand depletion on relative potencies of WT and 2D1 within one cell line. Cell growth was monitored over several days following incubation with various concentrations of WT or 2D1 (0 -100 pM). Cell numbers were essentially constant during the first 48 h of incubation, although cells were actively processing ligand (see Fig. 5 ). Proliferation between 48 and 72 h was equal to the ligand-free control at very low (1 pM) concentrations for both ligands. Both WT and 2D1 had equivalent potencies during this time at concentrations that saturate the high affinity IL-2 receptor (100 pM), suggesting that 2D1 does not generate superior signal transduction upon receptor binding. However, the growth rate of KIT-225 cells initially exposed to 10 pM 2D1 was roughly three times that of cells exposed to 10 pM WT from 48 to 72 h and reached essentially the maximum, not ordinarily seen for WT until 100 pM (Fig. 8) . This time period corresponded to that in which significantly increased numbers of cell surface ligandreceptor complexes were predicted for 2D1 relative to WT (see Fig. 7 ). Depletion effects have been shown to affect cell response under conditions wherein the number of ligand-receptor complexes is highly dependent on the concentration of active cytokine in the media (32) . This occurs at concentrations near or below the K D (ϳ10 pM for the high affinity IL-2 receptor). The altered intracellular trafficking fate of 2D1 directly heightens its mitogenic potency over WT in this concentration range.
T Cell Proliferation in Response to WT and 2D1-Bioactivity
Functional Response of NK Cells to IL-2 and 2D1-The pleiotropic immunologic effects of IL-2 include stimulation of NK cells through the intermediate affinity (IL-2R␤␥, K D ϭ 1 nM) IL-2 receptor. Because the 2D1 variant is known to bind this receptor with a lower affinity than wild-type IL-2 (see Table II) , we sought to quantify the relative response of NK cells to the two ligands. One indicator of NK cell activation in the presence of IL-2 is secretion of IFN-␥ (35, 59 -62) . To this end, YT-2C2 NK cells were incubated for 48 h with initial concentrations of 1 nM WT or 2D1 in the culture medium. This concentration is equivalent to the K D describing the binding of IL-2 with the IL-2 receptor expressed on these cells, and negligible binding to either of the individual ␤ or ␥ subunits occurs at this concentration. These cells were capable of specifically internalizing IL-2 analogs, and hence down-regulating their response to them, as evidenced by observable ligand depletion over the course of the experiment (Fig. 9) . Wild-type IL-2 was degraded to a greater extent than 2D1 via the intermediate-affinity IL-2 receptor. This result is consistent with the relative endocytic depletion seen in T cell culture via the high affinity IL-2R and highlights the functional significance of the ␤␥ complex in effecting cellular response. An enzyme-linked immunosorbent assay was used to quantify the amount of IFN-␥ present in the NK cell culture medium, and results indicated that these cells secreted a significantly greater amount of IFN-␥ in the presence of WT than was observed in response to 2D1 on a per-cell basis (Fig. 10) . This difference is qualitatively consistent with the reduced binding affinity of 2D1 to the ␤␥ IL-2 receptor and illustrates the diminished sensitivity of NK cells to an equivalent bolus of 2D1 relative to WT.
DISCUSSION
Our experimental data detailed here show that consideration of receptor-mediated trafficking phenomena can lead to engineered ligand variants with improved functional properties. This concept was previously suggested by studies with epidermal growth factor (63), and we now prove that it is generalizable to an immune system cytokine. The improved potency of 2D1 would not have been predicted from its binding affinity to the IL-2 receptor (␣␤␥) at the cell surface, yet it can be ex- (Fig. 3) were combined with receptor numbers determined from equilibrium binding studies (Fig. 4) plained by modified endosomal sorting leading to abrogated receptor-mediated depletion.
Following internalization of the IL-2/IL-2R complex into the endosomal compartment, wild-type IL-2 is typically sorted together with the ␤ and ␥ subunits of the IL-2 receptor toward lysosomal degradation, whereas the ␣ subunit is released to recycle back to the cell surface (31) . The enhanced recycling of 2D1 relative to WT correlates qualitatively with the heightened proclivity of the mutant to bind IL-2R␣ versus IL-2R␤ as pH is decreased. Denaturation studies have shown that although WT and the 2D1 variant display equivalent structural integrity at pH 7, the stability of 2D1 decreases relative to that of WT as pH is decreased to mimic transport through endocytic sorting vesicles. 2 These structural differences might directly affect conformation-dependent binding properties of 2D1 to the differentially sorted ␣, ␤, and ␥ IL-2R subunits at endosomal pH. Although the absolute difference in IL-2R␣ affinity between IL-2 and 2D1 at pH 6 does not point directly to a difference in recycling, the sensitivity of the ligand-receptor interaction to a pH change upon endocytosis is likely the relevant parameter in considering relative sorting outcomes as in the epidermal growth factor system (45) . Mutations that perturb ligand-receptor interactions in acidic endosomes and subsequently alter the intracellular trafficking of ligand-receptor complexes have also been identified in both the low density lipoprotein and insulin receptor systems (65) (66) (67) . The high affinity IL-2R system adds an additional level of complexity, and potentially an added route of intervention, based on the differential sorting of its distinct receptor subunits. Because IL-2 constantly undergoes endocytic turnover, mutations that cause slight differences in recycling efficiency can have profound effects on the effective ligand concentration in culture as illustrated in the present work.
From comparison of Figs. 2 and 4, it can be seen that a roughly 0.5-fold increase in ligand binding preference for the recycling receptor subunit relative to the degrading receptor subunit in this case yields an approximately 2-fold increase in the fraction of ligand sorted to recycling, from about 25% to about 50%. This manner of relationship between ligand-receptor binding and trafficking properties can be analyzed using a mathematical model previously described for the endosomal sorting process (68) . Furthermore, including Fig. 8 in the comparison demonstrates that this increase in sorting to recycling leads to an essentially 10-fold enhancement in ligand potency for stimulation of T cell proliferation. We infer that further increases in sorting to recycling, perhaps up to near 90% (which appears to be a constitutive maximum (46) ), may be obtained by rational or combinatorial engineering of IL-2 variants possessing a greater increase in binding preference for IL-2R␣ relative to IL-2R␤, and that such increases could lead to another 1-2 orders of magnitude enhancement of IL-2 potency.
The reduced binding affinity of 2D1 to the IL-2R ␤␥ complex expressed on NK cells should dampen induced inflammatory activity of these cells, as evidenced by the decrease in IFN-␥ secretion by the YT-2C2 cell line (69) . Secretion of IFN-␥ by NK cells can be an undesired side effect of IL-2 therapy directed at specific stimulation of the high affinity IL-2 receptor on T cells (20) . Thus, the 2D1 variant can be predicted to exhibit an expanded range of therapeutic efficacy, by maximizing potency with respect to activated T cells at low concentrations and minimizing of harmful side effects resulting from NK cell stimulation at high IL-2 concentrations.
Results gleaned from studies of the 2D1 variant can contribute to the concept of a cell-level dynamic analysis, involving "matrix" criteria related to optimization of multiple ligandreceptor binding properties within diverse cellular trafficking compartments (22) . For example, a more effective IL-2 variant should display increased affinity to both the ␣␤␥ IL-2R complex on the surface of T cells and to the constitutively recycling IL-2R␣ in postendocytic sorting vesicles, while maintaining decreased affinity to the ␤␥ IL-2R both on NK cells and under endosomal conditions wherein this complex is lysosomally routed. Utilization of the pH changes associated with transport through endocytic vesicles could be employed in a high throughput combinatorial manner or toward rational design based on the pH sensitivity of ligand-receptor binding interactions. An optimally reengineered IL-2 variant might affect not only enhanced T cell mitogenesis via improved postendocytic recycling efficiency but also reduced stimulation of NK cells upon exogenous delivery in vivo.
